However, some patients have reported feeling these symptoms after starting the medication
Ozempic and Wegovy are brand-name medications that are approved by the FDA and are not the same as the compounded medication
Semaglutide (Wegovy) for the treatment of obesity or weight management should not be used during pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm due to the potential hazard of maternal weight loss to the fetus
Semaglutide may reduce appetite and calorie intake, so patients may unintentionally eat too little protein during treatment
Enhancing Semaglutide Results with BioProtein Plus, NAD+, and Other Supplements Combining Semaglutide with targeted supplements can enhance fat loss, preserve muscle, and improve energy levels
One month defined as 1 bottle of 30 tablets